TW432073B
(en)
*
|
1995-12-28 |
2001-05-01 |
Pfizer |
Pyrazolopyridine compounds
|
HN1996000101A
(es)
*
|
1996-02-28 |
1997-06-26 |
Inc Pfizer |
Terapia combinada para la osteoporosis
|
PL201487B1
(pl)
|
1997-04-15 |
2009-04-30 |
Csir |
Sposób wytwarzania ekstraktu roślinnego, ekstrakt roślinny, środek o czynności hamowania łaknienia i zastosowanie ekstraktu roślinnego
|
GB2324726A
(en)
*
|
1997-05-01 |
1998-11-04 |
Merck & Co Inc |
Combination Therapy for the Treatment of Osteoporosis
|
UA64751C2
(uk)
|
1997-06-25 |
2004-03-15 |
Пфайзер Продактс Інк. |
Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти)
|
UA53716C2
(uk)
*
|
1997-06-25 |
2003-02-17 |
Пфайзер Продактс Інк. |
Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти)
|
US6251902B1
(en)
|
1997-06-25 |
2001-06-26 |
Pfizer Inc. |
Dipeptide derivatives as growth hormone secretagogues
|
ZA987383B
(en)
*
|
1997-08-19 |
2000-02-17 |
Lilly Co Eli |
Treatment of congestive heart failure with growth hormone secretagogues.
|
US6329342B1
(en)
|
1997-08-19 |
2001-12-11 |
Eli Lilly And Company |
Treatment of congestive heart failure with growth hormone secretagogues
|
US6893877B2
(en)
|
1998-01-12 |
2005-05-17 |
Massachusetts Institute Of Technology |
Methods for screening substances in a microwell array
|
WO1999036431A1
(en)
|
1998-01-16 |
1999-07-22 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
US6657063B1
(en)
*
|
1998-04-30 |
2003-12-02 |
Pfizer Inc. |
Combinations of β3 agonists and growth hormone secretagogues
|
KR20010052515A
(ko)
*
|
1998-06-03 |
2001-06-25 |
데이비드 존 우드 |
산화질소 신타아제 억제제로서 융합된 고리 치환체를함유하는 2-아미노피리딘
|
BR9911357A
(pt)
*
|
1998-06-16 |
2001-03-13 |
Pfizer Producs Inc |
Combinações terapêuticas de moduladores (seletivos) de receptor de estrogênio (serm) e secretagogos de hormÈnio de crescimento (ghs) para tratar fragilidade músculo-esqueletal
|
PE20000646A1
(es)
*
|
1998-06-16 |
2000-08-05 |
Pfizer Prod Inc |
Terapia de combinacion para la fragilidad musculoesqueletica
|
PA8471201A1
(es)
*
|
1998-06-16 |
2000-09-29 |
Pfizer Prod Inc |
Combinaciones terapeuticas que comprenden un modulador del receptor de estrogenos selectivo y hormona paratiroidea
|
US6639076B1
(en)
|
1998-08-18 |
2003-10-28 |
Eli Lilly And Company |
Growth hormone secretagogues
|
US6358951B1
(en)
|
1998-08-21 |
2002-03-19 |
Pfizer Inc. |
Growth hormone secretagogues
|
JP2002525274A
(ja)
*
|
1998-09-02 |
2002-08-13 |
メルク エンド カムパニー インコーポレーテッド |
成長ホルモン分泌促進剤による独立生活状況への復帰促進
|
CA2350638C
(en)
|
1998-09-11 |
2009-11-24 |
Gerhard Schmidmaier |
Biologically active implants coated with a biodegradable polymer
|
US6337332B1
(en)
|
1998-09-17 |
2002-01-08 |
Pfizer Inc. |
Neuropeptide Y receptor antagonists
|
US6380184B1
(en)
|
1998-10-28 |
2002-04-30 |
Bristol-Myers Squibb Co. |
Benzoazepines and analogs thereof useful as growth hormone secretagogues
|
US6194578B1
(en)
*
|
1998-11-20 |
2001-02-27 |
Pfizer Inc. |
Dipeptide derivatives
|
EP1486498A1
(en)
*
|
1998-11-23 |
2004-12-15 |
Pfizer Products Inc. |
Process and intermediates for growth hormone secretagogues
|
US6297380B1
(en)
*
|
1998-11-23 |
2001-10-02 |
Pfizer Inc. |
Process and intermediates for growth hormone secretagogues
|
WO2000048623A1
(en)
|
1999-02-18 |
2000-08-24 |
Kaken Pharmaceutical Co., Ltd. |
Novel amide derivatives as growth hormone secretagogues
|
US6828331B1
(en)
|
1999-02-19 |
2004-12-07 |
Eli Lilly And Company |
Growth hormone secretagogues
|
US6541634B2
(en)
*
|
1999-02-26 |
2003-04-01 |
Pfizer Inc. |
Process for preparing growth hormone secretagogues
|
US6518292B1
(en)
|
1999-03-12 |
2003-02-11 |
Bristol-Myers Squibb Co. |
Heterocyclic aromatic compounds usefuls as growth hormone secretagogues
|
US6525203B1
(en)
|
1999-03-12 |
2003-02-25 |
Bristol-Myers Squibb Company |
Heterocyclic aromatic compounds useful as growth hormone secretagogues
|
BR0012748A
(pt)
|
1999-07-26 |
2003-06-10 |
Baylor College Of Medcine |
Análogo super-ativo do hormÈnio de lberação do hormõnio do crescimento porcino
|
GB2355657B
(en)
|
1999-10-27 |
2004-07-28 |
Phytopharm Plc |
Inhibitors Of Gastric Acid Secretion
|
EP1113007A1
(en)
*
|
1999-12-24 |
2001-07-04 |
Pfizer Inc. |
Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
|
CA2395996A1
(en)
|
1999-12-28 |
2001-07-05 |
Kaken Pharmaceutical Co., Ltd. |
Neuroprotective drug
|
US20020151040A1
(en)
|
2000-02-18 |
2002-10-17 |
Matthew O' Keefe |
Apparatus and methods for parallel processing of microvolume liquid reactions
|
US7332271B2
(en)
*
|
2000-02-18 |
2008-02-19 |
Board Of Trustees Of The Leland Stanford Junior University |
Apparatus and methods for parallel processing of micro-volume liquid reactions
|
EP1132388A3
(en)
|
2000-03-09 |
2004-03-03 |
Pfizer Products Inc. |
Hexahydropyrazolo[4,3-c]pyridine metabolites
|
EP1149583A3
(en)
*
|
2000-04-13 |
2001-11-14 |
Pfizer Products Inc. |
Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues
|
AU2001259592B2
(en)
|
2000-05-11 |
2005-02-24 |
Bristol-Myers Squibb Co. |
Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
|
DOP2001000154A
(es)
*
|
2000-05-25 |
2002-05-15 |
Pfizer Prod Inc |
Combinación de secretagogos de hormona del crecimiento y antidepresivos
|
AU6497701A
(en)
|
2000-05-30 |
2001-12-11 |
Merck & Co Inc |
Melanocortin receptor agonists
|
EP1159964B1
(en)
|
2000-05-31 |
2009-10-28 |
Pfizer Products Inc. |
Use of growth hormone secretagogues for stimulating gastrointestinal motility
|
IL143690A0
(en)
*
|
2000-06-19 |
2002-04-21 |
Pfizer Prod Inc |
The use of growth hormone secretagogues to treat systemic lupus erythematosus and inflammatory bowel disease
|
EP1181933A3
(en)
*
|
2000-06-29 |
2002-04-10 |
Pfizer Products Inc. |
Use of growth hormone secretagogues for stimulating or increasing appetite
|
IL143942A0
(en)
*
|
2000-06-29 |
2002-04-21 |
Pfizer Prod Inc |
Use of growth hormone secretagogues for treatment of physical performance decline
|
GB2363985B
(en)
|
2000-06-30 |
2004-09-29 |
Phytopharm Plc |
Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
|
IL144468A0
(en)
*
|
2000-07-27 |
2002-05-23 |
Pfizer Prod Inc |
Use of growth hormone secretagogues for improvement of functional health status
|
MXPA03001771A
(es)
*
|
2000-08-30 |
2003-06-04 |
Pfizer Prod Inc |
Formulaciones de liberacion sostenida para secretagogos de hormona del crecimiento.
|
IL145106A0
(en)
*
|
2000-08-30 |
2002-06-30 |
Pfizer Prod Inc |
Intermittent administration of a geowth hormone secretagogue
|
IL145540A0
(en)
*
|
2000-09-28 |
2002-06-30 |
Pfizer Prod Inc |
Use of growth hormone secretagogues in conjunction with physical exercise
|
US20100261159A1
(en)
|
2000-10-10 |
2010-10-14 |
Robert Hess |
Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof
|
CA2425476C
(en)
*
|
2000-10-10 |
2011-02-01 |
Biotrove, Inc. |
Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof
|
CA2372450A1
(en)
*
|
2001-05-10 |
2001-09-19 |
Pharmaceutical Partners Of Canada Inc. |
Liquid injectable formulation of disodium pamidronate
|
US7125840B2
(en)
|
2001-10-09 |
2006-10-24 |
Eli Lilly And Company |
Substituted dipeptides as growth hormone secretagogues
|
WO2003041641A2
(en)
|
2001-11-09 |
2003-05-22 |
Bristol-Myers Squibb Company |
Tetrahydroisoquinoline analogs as modulators of chemokine receptor activity
|
US20030199514A1
(en)
*
|
2002-03-27 |
2003-10-23 |
Fryburg David A. |
Methods for improving efficacy of treatment with growth hormone secretagogues
|
ATE338767T1
(de)
*
|
2002-04-09 |
2006-09-15 |
Lilly Co Eli |
Dipeptidische wachstumshormonsekretionsförderern
|
US7105526B2
(en)
|
2002-06-28 |
2006-09-12 |
Banyu Pharmaceuticals Co., Ltd. |
Benzimidazole derivatives
|
US8277753B2
(en)
|
2002-08-23 |
2012-10-02 |
Life Technologies Corporation |
Microfluidic transfer pin
|
CN1688696A
(zh)
*
|
2002-09-18 |
2005-10-26 |
蒙特利尔大学医疗中心 |
Ghrh类似物
|
EP1608952B1
(en)
*
|
2002-12-20 |
2016-08-10 |
Life Technologies Corporation |
Assay apparatus and method using microfluidic arrays
|
US20060094108A1
(en)
*
|
2002-12-20 |
2006-05-04 |
Karl Yoder |
Thermal cycler for microfluidic array assays
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
WO2004108120A1
(en)
*
|
2003-06-11 |
2004-12-16 |
Pfizer Products Inc. |
Use of growth hormone secretagogues for treatment of fibromyalgia
|
US7476653B2
(en)
|
2003-06-18 |
2009-01-13 |
Tranzyme Pharma, Inc. |
Macrocyclic modulators of the ghrelin receptor
|
WO2005027913A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
|
CA2551037A1
(en)
|
2003-09-22 |
2005-03-31 |
Banyu Pharmaceutical Co., Ltd. |
Novel piperidine derivative
|
US7129561B2
(en)
*
|
2003-11-19 |
2006-10-31 |
International Business Machines Corporation |
Tri-metal and dual-metal stacked inductors
|
CA2559171A1
(en)
|
2004-03-12 |
2005-09-29 |
Biotrove, Inc. |
Nanoliter array loading
|
EP1734963A4
(en)
|
2004-04-02 |
2008-06-18 |
Merck & Co Inc |
METHOD FOR TREATING PEOPLE WITH METABOLIC AND ANTHROPOMETRIC DISORDER
|
WO2005097788A2
(en)
*
|
2004-04-02 |
2005-10-20 |
Elixir Pharmaceuticals, Inc. |
Sulfonamides and uses thereof
|
WO2005097174A2
(en)
*
|
2004-04-07 |
2005-10-20 |
Gastrotech Pharma A/S |
Uses of a combination of ghrelin and somatotropin for the treatment of cachexia
|
TW200614987A
(en)
|
2004-07-28 |
2006-05-16 |
Glaxo Group Ltd |
Novel compounds
|
US20060105453A1
(en)
|
2004-09-09 |
2006-05-18 |
Brenan Colin J |
Coating process for microfluidic sample arrays
|
JP2008509930A
(ja)
*
|
2004-08-12 |
2008-04-03 |
サファイア セラピューティクス インコーポレイテッド |
成長ホルモン分泌促進物質を利用して胃腸系の運動性を刺激する方法
|
EP2389941A1
(en)
|
2004-08-18 |
2011-11-30 |
Elixir Pharmaceuticals, Inc. |
Growth-hormone secretagogues
|
AU2006253312B2
(en)
|
2005-05-30 |
2011-08-18 |
Msd K.K. |
Novel piperidine derivative
|
JPWO2007018248A1
(ja)
|
2005-08-10 |
2009-02-19 |
萬有製薬株式会社 |
ピリドン化合物
|
DE602006017712D1
(de)
|
2005-08-24 |
2010-12-02 |
Banyu Pharma Co Ltd |
Phenylpyridonderivat
|
CA2621470A1
(en)
|
2005-09-07 |
2007-03-15 |
Banyu Pharmaceutical Co., Ltd. |
Bicyclic aromatic substituted pyridone derivative
|
WO2007041052A2
(en)
|
2005-09-29 |
2007-04-12 |
Merck & Co., Inc. |
Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
|
RU2008119687A
(ru)
|
2005-10-21 |
2009-11-27 |
Новартис АГ (CH) |
Комбинации органических соединений
|
US8163770B2
(en)
|
2005-10-27 |
2012-04-24 |
Msd. K. K. |
Benzoxathiin derivative
|
NZ568292A
(en)
|
2005-11-10 |
2011-08-26 |
Msd Kk |
Spiro[cyclohexane-1,1'-(3'H)-4'-azaisobenzofuran]-4-carboxamide derivatives
|
RU2420306C2
(ru)
*
|
2005-11-21 |
2011-06-10 |
Юниверсити Оф Миязаки |
ТЕРАПЕВТИЧЕСКОЕ СРЕДСТВО ДЛЯ УСКОРЕННОГО ЗАЖИВЛЕНИЯ КОЖИ, СОДЕРЖАЩЕЕ В КАЧЕСТВЕ АКТИВНОГО ИНГРЕДИЕНТА ГРЕЛИН И ЕГО ПРОИЗВОДНЫЕ ИЛИ ВЕЩЕСТВО, ВОЗДЕЙСТВУЮЩЕЕ НА РЕЦЕПТОР GHS-R1a
|
US8273702B2
(en)
*
|
2006-02-17 |
2012-09-25 |
Wake Forest University Health Sciences |
Wound healing compositions containing keratin biomaterials
|
CU23592A1
(es)
*
|
2006-02-28 |
2010-11-11 |
Ct Ingenieria Genetica Biotech |
Método para prevenir y eliminar las fibrosis y otras formas de depósito patológico en los tejidos aplicando el péptido secretagogo ghrp-6
|
CU23558A1
(es)
|
2006-02-28 |
2010-07-20 |
Ct Ingenieria Genetica Biotech |
Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
|
US20100227806A1
(en)
|
2006-03-10 |
2010-09-09 |
Tulipano Giovanni |
Use Of A Ghrelin Agonist To Improve Catabolic Effects Of Glucocorticoid Treatment
|
CA2858907A1
(en)
*
|
2006-09-08 |
2008-03-13 |
Bayer Schering Pharma Aktiengesellschaft |
Compounds and methods for 18f labeled agents
|
US8173629B2
(en)
|
2006-09-22 |
2012-05-08 |
Merck Sharp & Dohme Corp. |
Method of treatment using fatty acid synthesis inhibitors
|
US20090247560A1
(en)
|
2006-09-28 |
2009-10-01 |
Banyu Pharmaceutical Co., Ltd. |
Diaryl ketimine derivative
|
KR20090085599A
(ko)
*
|
2006-10-02 |
2009-08-07 |
바이엘 쉐링 파마 악티엔게젤샤프트 |
Pet 영상화용 규소 유도체
|
US20080114055A1
(en)
*
|
2006-11-10 |
2008-05-15 |
Zoltan Laboratories Llc |
Thioxanthone Compounds to Reverse Weight Loss
|
US9371297B2
(en)
|
2007-02-09 |
2016-06-21 |
Ocera Therapeutics, Inc. |
Macrocyclic ghrelin receptor modulators and methods of using the same
|
JP2010520229A
(ja)
*
|
2007-03-01 |
2010-06-10 |
バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト |
放射性弗素化方法
|
EP2368560A1
(en)
|
2007-03-12 |
2011-09-28 |
Zadec ApS |
An anti-diabetic extract of rooibos
|
EP2002835A1
(en)
|
2007-06-04 |
2008-12-17 |
GenKyo Tex |
Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
|
EP2145884B1
(en)
|
2007-04-02 |
2014-08-06 |
Msd K.K. |
Indoledione derivative
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
MX354786B
(es)
|
2007-06-04 |
2018-03-21 |
Synergy Pharmaceuticals Inc |
Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
|
JP5529014B2
(ja)
*
|
2007-06-12 |
2014-06-25 |
中国人民解放▲軍▼▲軍▼事医学科学院毒物▲薬▼物研究所 |
部位特異的なペグ化をされた直鎖状のサケカルシトニン類似体
|
US20110015181A1
(en)
|
2008-03-06 |
2011-01-20 |
Makoto Ando |
Alkylaminopyridine derivative
|
JPWO2009119726A1
(ja)
|
2008-03-28 |
2011-07-28 |
Msd株式会社 |
メラニン凝集ホルモン受容体拮抗作用を有するジアリールメチルアミド誘導体
|
EP3239170B1
(en)
|
2008-06-04 |
2019-03-20 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
AU2009261248A1
(en)
|
2008-06-19 |
2009-12-23 |
Banyu Pharmaceutical Co., Ltd. |
Spirodiamine-diarylketoxime derivative
|
EP3241839B1
(en)
|
2008-07-16 |
2019-09-04 |
Bausch Health Ireland Limited |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
AU2009277736A1
(en)
|
2008-07-30 |
2010-02-04 |
Banyu Pharmaceutical Co., Ltd. |
(5-membered)-(5-membered) or (5-membered)-(6-membered) fused ring cycloalkylamine derivative
|
EP2165707A1
(en)
|
2008-09-23 |
2010-03-24 |
Genkyo Tex Sa |
Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
|
EP2166009A1
(en)
|
2008-09-23 |
2010-03-24 |
Genkyo Tex Sa |
Pyrazolo pyridine derivatives as nadph oxidase inhibitors
|
EP2166010A1
(en)
|
2008-09-23 |
2010-03-24 |
Genkyo Tex Sa |
Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
|
MX2011004258A
(es)
|
2008-10-22 |
2011-06-01 |
Merck Sharp & Dohme |
Derivados de bencimidazol ciclicos novedosos utiles como agentes anti-diabeticos.
|
US8592457B2
(en)
|
2008-10-30 |
2013-11-26 |
Merck Sharp & Dohme Corp. |
Isonicotinamide orexin receptor antagonists
|
CA2741672A1
(en)
|
2008-10-31 |
2010-05-06 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
EP2305679A1
(en)
|
2009-09-28 |
2011-04-06 |
GenKyoTex SA |
Pyrazoline dione derivatives as nadph oxidase inhibitors
|
EP2361911A1
(en)
*
|
2010-02-18 |
2011-08-31 |
GenKyoTex SA |
Pyrazolo piperidine derivatives as NADPH oxidase inhibitors
|
EP2361912A1
(en)
|
2010-02-18 |
2011-08-31 |
GenKyoTex SA |
Pyrazolo piperidine derivatives as NADPH oxidase inhibitors
|
JP2013520502A
(ja)
|
2010-02-25 |
2013-06-06 |
メルク・シャープ・エンド・ドーム・コーポレイション |
有用な抗糖尿病薬である新規な環状ベンズイミダゾール誘導体
|
MX341660B
(es)
*
|
2010-02-26 |
2016-08-29 |
Raqualia Pharma Inc |
Agonista del receptor de ghrelina para el tratamiento de caquexia.
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
CN105001219A
(zh)
|
2011-02-25 |
2015-10-28 |
默沙东公司 |
用作抗糖尿病药剂的新的环状氮杂苯并咪唑衍生物
|
US8361964B2
(en)
*
|
2011-04-21 |
2013-01-29 |
Theratechnologies Inc. |
Growth hormone releasing factor (GRF) analogs and uses thereof
|
AR088352A1
(es)
|
2011-10-19 |
2014-05-28 |
Merck Sharp & Dohme |
Antagonistas del receptor de 2-piridiloxi-4-nitrilo orexina
|
EP2854810A4
(en)
*
|
2012-05-25 |
2016-04-06 |
Raqualia Pharma Inc |
GHRELIN RECEPTOR AGONISTS FOR THE TREATMENT OF ACHLORHYDRIA
|
RU2015106909A
(ru)
|
2012-08-02 |
2016-09-27 |
Мерк Шарп И Доум Корп. |
Антидиабетические трициклические соединения
|
TWI667024B
(zh)
|
2012-09-27 |
2019-08-01 |
美商雅瑞塔那醫療公司 |
使用食慾喪失控制化合物之組合物及方法
|
AU2013335678B2
(en)
|
2012-10-24 |
2017-10-26 |
Daiichi Sankyo Company,Limited |
Therapeutic agent for amyotrophic lateral sclerosis
|
JP2016516004A
(ja)
|
2013-02-22 |
2016-06-02 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
抗糖尿病二環式化合物
|
JP2016514671A
(ja)
|
2013-03-15 |
2016-05-23 |
シナジー ファーマシューティカルズ インコーポレイテッド |
グアニル酸シクラーゼのアゴニストおよびその使用
|
CA2905435A1
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Compositions useful for the treatment of gastrointestinal disorders
|
US9499543B2
(en)
*
|
2013-05-28 |
2016-11-22 |
Raqualia Pharma Inc. |
Polymorph forms
|
EP3004138B1
(en)
|
2013-06-05 |
2024-03-13 |
Bausch Health Ireland Limited |
Ultra-pure agonists of guanylate cyclase c, method of making and using same
|
KR102051433B1
(ko)
*
|
2013-08-27 |
2020-01-08 |
(주)네오팜 |
근육 분화 촉진 및 근육 강화용 조성물 및 외용제
|
US9119832B2
(en)
|
2014-02-05 |
2015-09-01 |
The Regents Of The University Of California |
Methods of treating mild brain injury
|
CN106459147B
(zh)
*
|
2014-08-05 |
2021-08-06 |
拉夸里亚创药株式会社 |
作为生长激素释放肽受体激动剂的丝氨酸衍生物
|
CN113121450A
(zh)
|
2014-08-29 |
2021-07-16 |
Tes制药有限责任公司 |
α-氨基-β-羧基粘康酸半醛脱羧酶抑制剂
|
TW201625613A
(zh)
|
2014-10-31 |
2016-07-16 |
拉夸里亞創藥股份有限公司 |
作為生長激素釋放肽受體激動劑之四氫吡唑並吡啶衍生物
|
US20170121385A1
(en)
|
2015-10-28 |
2017-05-04 |
Oxeia Biopharmaceuticals, Inc. |
Methods of treating neurodegenerative conditions
|
CA3038185A1
(en)
|
2016-10-14 |
2018-04-19 |
Tes Pharma S.R.L. |
Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
|
EP3479843A1
(en)
|
2017-11-01 |
2019-05-08 |
GenKyoTex Suisse SA |
Use of nox inhibitors for treatment of cancer
|
CN109320515A
(zh)
*
|
2018-11-22 |
2019-02-12 |
常州大学 |
一种Capromorelin手性中间体的不对称合成方法
|
EP3924058A1
(en)
|
2019-02-13 |
2021-12-22 |
Merck Sharp & Dohme Corp. |
5-alkyl pyrrolidine orexin receptor agonists
|